FSMDX
Price
$35.16
Change
+$0.31 (+0.89%)
Updated
Jun 26 closing price
Net Assets
40.4B
JACNX
Price
$28.50
Change
+$0.39 (+1.39%)
Updated
Jun 26 closing price
Net Assets
4.42B
Interact to see
Advertisement

FSMDX vs JACNX

Header iconFSMDX vs JACNX Comparison
Open Charts FSMDX vs JACNXBanner chart's image
Fidelity Mid Cap Index
Price$35.16
Change+$0.31 (+0.89%)
VolumeN/A
Net Assets40.4B
Janus Henderson Contrarian D
Price$28.50
Change+$0.39 (+1.39%)
VolumeN/A
Net Assets4.42B
FSMDX vs JACNX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSMDX vs. JACNX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMDX is a Buy and JACNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 40.4B vs. JACNX (4.43B). FSMDX pays higher dividends than JACNX: FSMDX (1.14) vs JACNX (0.44). FSMDX was incepted earlier than JACNX: FSMDX (14 years) vs JACNX (25 years). JACNX (0.64) is less costly to investors than FSMDX (0.03). JACNX is a more actively managed with annual turnover of: 42.00 vs. FSMDX (8.00). FSMDX has a lower initial minimum investment than JACNX: FSMDX (0) vs JACNX (2500). FSMDX annual gain was more profitable for investors over the last year : 12.60 vs. JACNX (4.67). FSMDX return over 5 years is better than : 79.09 vs. JACNX (48.27).
FSMDXJACNXFSMDX / JACNX
Total Expense Ratio0.030.644%
Annual Report Gross Expense Ratio0.030.644%
Fund Existence14 years25 years-
Gain YTD3.1982.888111%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets40.4B4.43B913%
Annual Yield % from dividends1.140.44258%
Returns for 1 year12.604.67270%
Returns for 3 years40.7022.47181%
Returns for 5 years79.0948.27164%
Returns for 10 years116.8745.21259%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ERHSX13.91N/A
N/A
Eaton Vance Worldwide Health Sci R
VAFRX28.41N/A
N/A
Invesco American Franchise R
HRLAX9.19N/A
N/A
Hartford Real Asset A
GOFFX49.92N/A
N/A
Invesco Global Opportunities R5
EARAX14.88N/A
N/A
Eaton Vance RBA All Asset Strategy Fd A